Authors
Howell, AnthonyAffiliation
CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, M20 4BX, UK. maria.parker@christie-tr.nwest.nhs.ukIssue Date
2005-08
Metadata
Show full item recordCitation
Adjuvant aromatase inhibitors for breast cancer., 366 (9484):431-3 LancetJournal
LancetDOI
10.1016/S0140-6736(05)67036-5PubMed ID
16084234Type
ArticleLanguage
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(05)67036-5
Scopus Count
Collections
Related articles
- Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.
- Authors: Buzdar AU
- Issue date: 2007 May 20
- ATAC trial update.
- Authors: de Castro G Jr
- Issue date: 2005 Apr 2-8
- Aromatase inhibitors--a triumph of translational oncology.
- Authors: Swain SM
- Issue date: 2005 Dec 29
- Extended adjuvant therapy for breast cancer--how much is enough?
- Authors: Prowell TM, Stearns V
- Issue date: 2007 Dec 19
- Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.
- Authors: Chlebowski R, Cuzick J, Amakye D, Bauerfeind I, Buzdar A, Chia S, Cutuli B, Linforth R, Maass N, Noguchi S, Robidoux A, Verma S, Hadji P
- Issue date: 2009 Aug